The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia
Current Opinion in Lipidology, 08/03/2012
Wu X et al. – The findings suggest a unified molecular explanation for fatty liver, atherogenic dyslipoproteinemia, hyperglycemia, and hence accelerated atherosclerosis and microvascular disease in Type 2 diabetes mellitus (T2DM), obesity, and related syndromes of positive caloric imbalance.



